MedTrace Logo

Targeting IRAK4 in Chronic Lymphocytic Leukemia

NCT07741695 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-08-04

No results posted yet for this study

Summary

Patients with chronic lymphocytic leukemia (CLL) followed at Strategic Research Program on CLL will be enrolled and undergo sampling of additional amount of blood at the time of standard blood tests. Leukemic B cells and peripheral blood mononuclear cells (PBMC).

Conditions

  • Chronic Lymphocytic Leukemia (CLL)

Interventions

PROCEDURE

Peripheral blood sample collection

Up to 50 ml of blood will be collected for the research project at the time of standard blood tests.

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-09-30
Completion
2027-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07741695 on ClinicalTrials.gov